These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34170908)

  • 1. OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST).
    Hamo CE; Abdelmoneim SS; Han SY; Chandy E; Muntean C; Khan SA; Sunkesula P; Meykler M; Ramachandran V; Rosenberg E; Klem I; Sacchi TJ; Heitner JF
    PLoS One; 2021; 16(6):e0253014. PubMed ID: 34170908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
    Okuhara Y; Hirotani S; Ando T; Nishimura K; Orihara Y; Komamura K; Naito Y; Mano T; Masuyama T
    Heart Vessels; 2017 Apr; 32(4):419-427. PubMed ID: 27469321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
    Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
    J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
    Palazzuoli A; Pellegrini M; Ruocco G; Martini G; Franci B; Campagna MS; Gilleman M; Nuti R; McCullough PA; Ronco C
    Crit Care; 2014 Jun; 18(3):R134. PubMed ID: 24974232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction.
    Zheng Z; Jiang X; Chen J; He D; Xie X; Lu Y
    ESC Heart Fail; 2021 Jun; 8(3):2070-2078. PubMed ID: 33689236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
    Rahhal A; Saad MO; Tawengi K; Assi AAR; Habra M; Ahmed D
    BMC Cardiovasc Disord; 2019 May; 19(1):127. PubMed ID: 31138146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.
    Giamouzis G; Butler J; Starling RC; Karayannis G; Nastas J; Parisis C; Rovithis D; Economou D; Savvatis K; Kirlidis T; Tsaknakis T; Skoularigis J; Westermann D; Tschöpe C; Triposkiadis F
    J Card Fail; 2010 Dec; 16(12):922-30. PubMed ID: 21111980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
    Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
    Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.
    Singh D; Shrestha K; Testani JM; Verbrugge FH; Dupont M; Mullens W; Tang WH
    J Card Fail; 2014 Jun; 20(6):392-9. PubMed ID: 24704538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of continuous infusion loop diuretics in patients with acute decompensated heart failure with hypoalbuminemia.
    Bleske BE; Clark MM; Wu AH; Dorsch MP
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):334-7. PubMed ID: 23424098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure.
    Gilotra NA; Princewill O; Marino B; Okwuosa IS; Chasler J; Almansa J; Cummings A; Rhodes P; Chambers J; Cuomo K; Russell SD
    JACC Heart Fail; 2018 Jan; 6(1):65-70. PubMed ID: 29226816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.
    Yayla Ç; Akyel A; Canpolat U; Gayretli Yayla K; Eyiol A; Akboğa MK; Türkoğlu S; Tavil Y; Boyacı B; Çengel A
    Herz; 2015 Dec; 40(8):1115-20. PubMed ID: 26135463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretic strategies in patients with acute decompensated heart failure.
    Felker GM; Lee KL; Bull DA; Redfield MM; Stevenson LW; Goldsmith SR; LeWinter MM; Deswal A; Rouleau JL; Ofili EO; Anstrom KJ; Hernandez AF; McNulty SE; Velazquez EJ; Kfoury AG; Chen HH; Givertz MM; Semigran MJ; Bart BA; Mascette AM; Braunwald E; O'Connor CM;
    N Engl J Med; 2011 Mar; 364(9):797-805. PubMed ID: 21366472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.
    Llorens P; Miró Ò; Herrero P; Martín-Sánchez FJ; Jacob J; Valero A; Alonso H; Pérez-Durá MJ; Noval A; Gil-Román JJ; Zapater P; Llanos L; Gil V; Perelló R
    Emerg Med J; 2014 Sep; 31(9):706-13. PubMed ID: 23793945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial.
    Piardi DS; Butzke M; Mazzuca ACM; Gomes BS; Alves SG; Kotzian BJ; Ghisleni EC; Giaretta V; Bellaver P; Varaschin GA; Garbin AP; Beck-da-Silva L
    Sci Rep; 2021 Aug; 11(1):16474. PubMed ID: 34389780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The risks of re-hospitalization of patients with heart failure with prolonged follow-up in a specialized center for the treatment of heart failure and in real clinical practice.].
    Vinogradova NG; Polyakov DS; Fomin IV
    Kardiologiia; 2020 Jan; 60(3):59-69. PubMed ID: 32375617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.